Methotrexate Therapy in Deep Venous Thrombosis in Behcet Disease in

Behcet disease is a chronic condition, systemic disease, with etiopathology still incomplete known but in witch are involved immune and genetic factors who may lead to inflammation and coagulation conditions. Authors present the case of a patient, masculine sex, 14 years old, diagnosed with Behcet disease, who had the vascular manifestation, with deep and superficial lower extremity vein thrombosis, that appeared at more than five years after first signs of disease (recurrent oral ulcerations). The patient had not presented positive markers for primary thrombophilia. Methotrexate therapy led to complete disappearance of lower extremity vein thrombosis, after about one year of treatment (as shown in Doppler vascular ultrasound). No side effect was observed related to Methotrexate therapy. Conclusions: Methotrexate therapy may be a very efficient alternative treatment in deep lower extremity vein thrombosis in Behcet disease, without anticoagulants association.

[1]  J. Piette,et al.  Immunosuppressants reduce venous thrombosis relapse in Behçet's disease. , 2012, Arthritis and rheumatism.

[2]  M. Owlia,et al.  Behcet's Disease: New Concepts in Cardiovascular Involvements and Future Direction for Treatment , 2012, ISRN pharmacology.

[3]  J. Piette,et al.  Spectrum of Cardiac Lesions in Behçet Disease: A Series of 52 Patients and Review of the Literature , 2012, Medicine.

[4]  M. Schirmer,et al.  Major vessel involvement in Behçet's disease: an update , 2011, Current opinion in rheumatology.

[5]  P. Mehta,et al.  Thrombosis and Behçet's syndrome in non-endemic regions. , 2010, Rheumatology.

[6]  H. Ben Maiz,et al.  [Renal involvement in Behcet's disease]. , 2010, La Tunisie medicale.

[7]  K. Calamia,et al.  Behçet’s disease: an update on pathogenesis, diagnosis and management of vascular involvement , 2010 .

[8]  G. Cocco,et al.  Behçet’s Disease: an Insight from a Cardiologist’s Point of View , 2010, The open cardiovascular medicine journal.

[9]  A. Bakkaloğlu,et al.  Behçet disease: treatment of vascular involvement in children , 2010, European Journal of Pediatrics.

[10]  Z. Tazi-Mezalek,et al.  [Vascular involvement in Behcet's disease]. , 2009, La Revue de medecine interne.

[11]  Ali-asghar Ebrahimi,et al.  Renal involvement in Behcet's disease. , 2009, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[12]  I. Kötter [EULAR recommendations for the management of Behçet's disease. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)]. , 2009, Zeitschrift fur Rheumatologie.

[13]  R. Santiago Behcets Syndrome: Literature Review , 2009 .

[14]  A. Silman,et al.  Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease , 2008, Annals of the rheumatic diseases.

[15]  L. Ramón,et al.  Fibrinolytic inhibitor levels and polymorphisms in Behçet disease and their association with thrombosis , 2008, British journal of haematology.

[16]  M. Borlu,et al.  Demographic and clinical properties of juvenile-onset Behçet's disease: A controlled multicenter study. , 2008, Journal of the American Academy of Dermatology.

[17]  A. Silman,et al.  EULAR recommendations for the management of Behçet disease , 2008, Annals of the rheumatic diseases.

[18]  H. Yazici,et al.  The Unique Features of Vasculitis in Behçet’s Syndrome , 2008, Clinical reviews in allergy & immunology.

[19]  C. Korkmaz Is anticoagulation unnecessary in Behcet’s disease with deep venous thrombosis? , 2008, Clinical Rheumatology.

[20]  E. Koh,et al.  Treatment of venous thrombosis associated with Behcet’s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation , 2008, Clinical Rheumatology.

[21]  B Combe,et al.  EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) , 2006, Annals of the rheumatic diseases.

[22]  R. Dişçi,et al.  Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases , 2006, International journal of dermatology.

[23]  Ö. Demir,et al.  Characteristics of vascular involvement in Behçet's disease , 2006, Scandinavian journal of rheumatology.

[24]  H. Yazıcı,et al.  Fibrinolytic activity and d-dimer levels in Behçet's syndrome. , 2005, Clinical and experimental rheumatology.

[25]  M. Ehrenfeld,et al.  Thrombophilic factors are not the leading cause of thrombosis in Behçet’s disease , 2004, Annals of the rheumatic diseases.

[26]  C. Zouboulis Extended venous thrombosis in Adamantiades-Behçet's disease. , 2004, European journal of dermatology : EJD.

[27]  I. Olivieri,et al.  Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. , 2004, Arthritis and rheumatism.

[28]  Murat Ugurlucan,et al.  Les manifestations vasculaires de la Maladie de Behçet : à propos d'un cas , 2004 .

[29]  F. Shahram,et al.  LARGE VESSEL INVOLVEMENT IN BEHCET’S DISEASE , 2004 .

[30]  İ. Tuğal-Tutkun,et al.  Childhood-onset uveitis in Behçet disease:a descriptive study of 36 cases. , 2003, American journal of ophthalmology.

[31]  R. Vaughan,et al.  Behçet’s disease: from Hippocrates to the third millennium , 2003, The British journal of ophthalmology.

[32]  N. Seyahi,et al.  The Long-Term Mortality and Morbidity of Behçet Syndrome: A 2-Decade Outcome Survey of 387 Patients Followed at a Dedicated Center , 2003, Medicine.

[33]  Sang-Woon Choi,et al.  Coagulation parameters and plasma total homocysteine levels in Behcet's disease. , 2002, Thrombosis research.

[34]  G. Espinosa,et al.  Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. , 2002, The American journal of medicine.

[35]  I. Ben Ghorbel,et al.  Deep vein thrombosis in Behçet's disease. , 2001, Clinical and experimental rheumatology.

[36]  A. Denman,et al.  Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. , 2001, Rheumatology.

[37]  A. Elhan,et al.  Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease. , 2000, The Journal of rheumatology.

[38]  A. Gürler,et al.  Comparison of Coagulation Parameters for Healthy Subjects and Behçet Disease Patients with and without Vascular Involvement , 2000, World Journal of Surgery.

[39]  A. Siegbahn,et al.  Haemostasis in patients with Behçet's disease. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[40]  O. Ozcebe,et al.  Behçet's disease. , 2019, The New England journal of medicine.

[41]  I. Ben Ghorbel,et al.  [Vena cava thrombosis in Behçet's disease. Analysis of a series of 10 cases]. , 1999, Annales de medecine interne.

[42]  I. Lavi,et al.  Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease. , 1999, The Journal of rheumatology.

[43]  C. Zouboulis,et al.  Twenty-Eight Cases of Juvenile-Onset Adamantiades-Behçet Disease in Germany , 1999, Dermatology.

[44]  C. Santosh,et al.  Cerebral venous thrombosis in Behçet’s disease , 1997, Journal of neurology, neurosurgery, and psychiatry.

[45]  J. Braun,et al.  IgA nephropathy in a patient with Behçet's syndrome--case report and review of literature. , 1997, British journal of rheumatology.

[46]  M. Siepmann,et al.  Coronary anomaly in Behçet's syndrome , 1997, Rheumatology International.

[47]  Y. Tüzün,et al.  Azathioprine in Behcet's syndrome: effects on long-term prognosis. , 1997, Arthritis and rheumatism.

[48]  A. Hernigou,et al.  Endomyocardial fibrosis in Behçet’s disease , 1997, Annals of the rheumatic diseases.

[49]  G. Ehrlich Vasculitis in Behçet's disease. , 1997, International reviews of immunology.

[50]  A. Iliopoulos,et al.  A case of Adamantiadis-Behçet's syndrome presenting as myocardial infarction. , 1993, Clinical and experimental rheumatology.

[51]  M. Tanaka,et al.  IgA nephritis in Behçet's disease: case report and review of the literature. , 1990, Clinical nephrology.

[52]  Y. Doi,et al.  Aortic regurgitation secondary to Behçet's disease. A case report and review of the literature. , 1990, European heart journal.

[53]  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. , 1990, Lancet.

[54]  Calvin G. Barnes,et al.  A controlled trial of azathioprine in Behçet's syndrome. , 1990, The New England journal of medicine.

[55]  S. Hammill,et al.  Cardiac involvement in Behçet's disease. , 1985, Arthritis and rheumatism.

[56]  M. Chamberlain,et al.  A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease. , 1984, Annals of the rheumatic diseases.

[57]  J. Miller,et al.  Behcet's disease presenting as chronic aphthous stomatitis in a child. , 1978, Pediatrics.

[58]  A. Silman,et al.  [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.

[59]  A. Pina,et al.  [Behcet syndrome]. , 1952, Jornal do medico.